Related Experiment Videos
[The prognosis of Wilm's tumor in childhood]
Insights
Pediatric Wilms' tumor treatment in Magdeburg achieved an 87% five-year survival rate. Therapy was individualized, and reduced treatment intensity maintained high survival, with preoperative chemotherapy introduced in 1989.
Area of Science:
- Pediatric Oncology
- Nephrology
Background:
- Wilms' tumor is a significant pediatric kidney cancer.
- Effective treatment protocols are crucial for improving survival rates in children.
Purpose of the Study:
- To analyze the treatment outcomes and survival rates of pediatric Wilms' tumor patients.
- To evaluate the impact of individualized therapy and reduced treatment intensity on survival.
Main Methods:
- Retrospective analysis of 33 children with Wilms' tumor treated between January 1974 and June 1990.
- Treatment regimens were adapted based on patient age, tumor stage, and histological subtype.
- Introduction of preoperative chemotherapy in 1989 as part of the European International Society of Pediatric Oncology Nephroblastoma study No 9.
Main Results:
- A cumulative five-year survival rate of 0.87 was achieved.
- High survival rates were maintained despite a significant reduction in therapy intensity over the observation period.
- The introduction of preoperative chemotherapy aimed to further enhance treatment efficacy.
Conclusions:
- Individualized treatment strategies for pediatric Wilms' tumor can achieve high survival rates.
- Reduced therapy intensity is feasible without compromising survival outcomes.
- Ongoing research and international collaboration, such as the Nephroblastoma study, are vital for advancing pediatric cancer treatment.
Abstract:
From January 1974 to June 1990 33 children suffering from Wilms' tumor were treated at the Department of Pediatrics of the Magdeburg Medical Academy. The cumulative five year survival rate was 0.87. The treatment regimen depended on age of patient, stage and histological subclassification of tumor. In spite of an impressive reduction of therapy during the observation period the survival rate of patients remained high. Since 1989 the Nephroblastoma study No 9 of the European International Society of Pediatric Oncology has been applied to improve furthermore the treatment by a preoperative chemotherapy in all patients.